Rational design of allosteric modulators: Challenges and successes
A Chatzigoulas, Z Cournia - Wiley Interdisciplinary Reviews …, 2021 - Wiley Online Library
… of targets leading to the establishment of rational design of allosteric modulators as a new
… property of the protein conformational ensemble, allosteric drug design has the potential to …
… property of the protein conformational ensemble, allosteric drug design has the potential to …
Recent trends in rationally designed molecules as kinase inhibitors
… of rationally designed kinase inhibitors and their application in the management of malignancies.
Scheme 1 illustrates the interplay between different kinases in … kinase inhibitors [8-53]. …
Scheme 1 illustrates the interplay between different kinases in … kinase inhibitors [8-53]. …
Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials
F Manetti - European journal of medicinal chemistry, 2018 - Elsevier
… rationally design small molecules able to inhibit LIMK activity selectively, without affecting
other kinases. … (the so called DFG-out inactive conformation of kinases), thus providing a strong …
other kinases. … (the so called DFG-out inactive conformation of kinases), thus providing a strong …
Trends in kinase drug discovery: targets, indications and inhibitor design
… The salt bridge between αC E501 and K483 is not present in this inactive conformation. f |
Example of a type 3 inhibitor binding mode in the kinase … Strategies for rational inhibitor design …
Example of a type 3 inhibitor binding mode in the kinase … Strategies for rational inhibitor design …
Protein allostery in rational drug design
T Kinoshita - Protein Allostery in Drug Discovery, 2019 - Springer
… The Type-I inhibitor binds to the DFG-in conformation and has no involvement in the R-spine…
-II inhibitor binds to the DFG-out conformation and the hydrophobic moiety of the inhibitor …
-II inhibitor binds to the DFG-out conformation and the hydrophobic moiety of the inhibitor …
Rational drug design of Axl tyrosine kinase type I inhibitors as promising candidates against cancer
E Sarukhanyan, S Shityakov, T Dandekar - Frontiers in Chemistry, 2020 - frontiersin.org
… In the current study, we introduce systematic computational analysis for the DFG-in conformation
of the Axl kinase to inhibit its activity using different sets of molecular docking algorithms …
of the Axl kinase to inhibit its activity using different sets of molecular docking algorithms …
In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
… and inactive kinase conformations … for rational design of allosteric modulators, the authors
of this study opened an exciting avenue for future discovery of novel class of kinase inhibitors …
of this study opened an exciting avenue for future discovery of novel class of kinase inhibitors …
Conformation-selective analogues of dasatinib reveal insight into kinase inhibitor binding and selectivity
FE Kwarcinski, KR Brandvold, S Phadke… - ACS chemical …, 2016 - ACS Publications
… of inhibitors represent the first set of kinase inhibitors that bind the active, DFG-out inactive,
and αC-helix-out conformations … kinase conformation impacts inhibitor binding and selectivity. …
and αC-helix-out conformations … kinase conformation impacts inhibitor binding and selectivity. …
Dual-target kinase drug design: Current strategies and future directions in cancer therapy
D Sun, Y Zhao, S Zhang, L Zhang, B Liu… - European Journal of …, 2020 - Elsevier
… site with DFG-in conformation, while Type II inhibitors bind to protein kinase with the DFG …
target kinase inhibitors is conducive to the rational design of a dual- or even multi-target kinase …
target kinase inhibitors is conducive to the rational design of a dual- or even multi-target kinase …
Fragment-based drug design facilitates selective kinase inhibitor discovery
ZZ Wang, XX Shi, GY Huang, GF Hao… - Trends in Pharmacological …, 2021 - cell.com
… and bind into the highly conserved ATP binding site of kinases. The large number of PKs and
other type of ATP-binding … exhibited conserved binding conformation at the same protein [ …
other type of ATP-binding … exhibited conserved binding conformation at the same protein [ …